SINGAPORE'S troubled Fullerton Healthcare (Fullerton Health) could be left with little option but to go down the judicial management (JM) path as time runs out and a sour shareholder stand-off jeopardises any potential sale to rescue the private healthcare solutions firm.

"Clearly, the (sale) process has gone on for very long with a lot of names thrown around... this sale has not materialised for various reasons and this has led to this whole conversation on JM," a reliable source told The Business Times (BT).

Fullerton Health, a "pan-regional platform" that offers corporations everything from health insurance plans and access to a network of healthcare providers to benefit plans, and also provides primary care and diagnostics, counts Hong Kong-based private equity (PE) firm RRJ Capital as its largest creditor.